Fly News Breaks for June 3, 2019
Jun 3, 2019 | 07:58 EDT
Canaccord analyst Jason Mills noted Merit Medical shares were weak following President Trump's threat to impose a 5% tariff on all goods from Mexico. The company currently manufactures roughly $120M in annual product revenues out of Mexico but the analyst said the lack of details from the President and a presumption of a soft deadline of June 10th, has provided a compelling entry point for investors. Mills reiterated his Buy rating and $63 price target on Merit Medical shares.
News For MMSI From the Last 2 Days
There are no results for your query MMSI